Skip to content
10-K

Annual Report

BIOADAPTIVES, INC. BDPT

0001640334-25-000660

← back to feed
Filed
Apr 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 21, 2025 9.05M sh
Eps Basic FY 2024 · Dec 31, 2024 −$0.11
Eps Basic FY 2024 · Dec 31, 2023 −$0.12
Operating Cash Flow FY 2024 · Dec 31, 2023 −$223.77K
Cash And Equivalents restated FY 2024 · Dec 31, 2023 $88.56K
Current Liabilities FY 2024 · Dec 31, 2023 $1.75M
Total Liabilities FY 2024 · Dec 31, 2023 $1.75M
Current Assets FY 2024 · Dec 31, 2023 $88.56K
Total Assets FY 2024 · Dec 31, 2023 $104K
Sga Expense FY 2024 · Dec 31, 2023 $101.48K
Net Income FY 2024 · Dec 31, 2023 −$712.47K
Operating Income FY 2024 · Dec 31, 2023 −$228.92K
Gross Profit FY 2024 · Dec 31, 2023 $10.82K
Cost Of Revenue FY 2024 · Dec 31, 2023 $17.75K
Revenue FY 2024 · Dec 31, 2023 $28.57K
Stockholders Equity FY 2024 · Dec 31, 2022 −$1.45M